Developmental biology

Psomagen Puts Spatial Biology and Multiomics in Focus, first CRO to launch 10X Genomics Xenium™ in situ Analyzer services in North America

Retrieved on: 
Tuesday, September 12, 2023

ROCKVILLE, Md., Sept. 12, 2023 /PRNewswire/ -- Multiomics CRO Psomagen is thrilled to announce the launch of Spatial Biology services for 10X Genomics Xenium™.

Key Points: 
  • ROCKVILLE, Md., Sept. 12, 2023 /PRNewswire/ -- Multiomics CRO Psomagen is thrilled to announce the launch of Spatial Biology services for 10X Genomics Xenium™.
  • According to Psomagen CEO Dr. Su Hong , "Psomagen's omics expertise makes us the perfect partner for North American customers."
  • Psomagen is a trusted Contract Research Organization (CRO) with nearly 20 years of genomics experience.
  • "Introducing spatial biology marks a pivotal moment in the evolution of Psomagen as a multiomics provider," stated Dr. Su Hong.

Cystic Fibrosis Foundation Announces New Members of Board of Trustees

Retrieved on: 
Wednesday, August 9, 2023

Today, the Cystic Fibrosis Foundation announced changes to its Board of Trustees, including the election of Kate O’Donnell, MBA, and Dodzie Sogah, PhD, as trustees, and Elise Eberwein, MBA, as a non-voting advisor.

Key Points: 
  • Today, the Cystic Fibrosis Foundation announced changes to its Board of Trustees, including the election of Kate O’Donnell, MBA, and Dodzie Sogah, PhD, as trustees, and Elise Eberwein, MBA, as a non-voting advisor.
  • View the full release here: https://www.businesswire.com/news/home/20230809016427/en/
    The Cystic Fibrosis Foundation announced new members of its Board of Trustees: Kate O’Donnell, MBA, and Dodzie Sogah, PhD, as trustees, and Elise Eberwein, MBA, as a non-voting advisor.
  • (From left to right, O’Donnell, Sogah, and Eberwein) (Photo: Business Wire)
    “The CF Foundation Board of Trustees plays a critical role in shaping the Foundation’s vision as we continue to meet the rapidly evolving needs of the CF community,” said KC White, chair of the Board of Trustees.
  • The Joey Fund has raised hundreds of millions of dollars on behalf of the CF Foundation.

Zebrafish are a scientist's favorite for early-stage research – especially to study human blood disorders

Retrieved on: 
Monday, August 7, 2023

But not just any organism can adequately model how human cells behave.

Key Points: 
  • But not just any organism can adequately model how human cells behave.
  • In the Espín Lab at Iowa State University, we study the early stages of blood development, particularly the birth of blood stem cells, which happens only once during embryonic development.
  • Although we want to understand how these genes work in the context of human blood development, testing on human embryos is obviously ethically impossible.

Zebrafish as a model organism

    • Zebrafish have several traits that make them excellent model organisms.
    • One day of development in zebrafish is equivalent to approximately 90 days of human development.
    • Approximately 70% of zebrafish genes have similar analogs in people, allowing researchers to study how certain genes work.

Studying blood disorders with zebrafish

    • Beyond sharing a significant percentage of genes with people, zebrafish are especially useful to blood development research because they produce the same types of blood cells.
    • Mature blood cells are derived from blood stem cells.
    • Therefore, studying how these stem cells are made would aid in developing treatment for numerous blood disorders that rely on blood stem cell therapies, such as leukemia, lymphoma and anemia.
    • Labs like ours use zebrafish to study how specific cell signaling pathways contribute to the birth, development and maturation of these blood stem cells.

Honeycomb Biotechnologies and Revvity Launch New Solutions to Expand the Frontiers of Single Cell Research

Retrieved on: 
Thursday, June 29, 2023

Today, in collaboration with single cell genomics company, Honeycomb Biotechnologies (“Honeycomb”), Revvity (NYSE: RVTY) announced the launch of a suite of new solutions and services that expand the frontiers of single cell biology: the HIVE™ CLX Single-Cell RNAseq Solution , BeeNetPLUS analysis workflow, and for single cell researchers based in the United States, a new HIVE CLX Service offering.

Key Points: 
  • Today, in collaboration with single cell genomics company, Honeycomb Biotechnologies (“Honeycomb”), Revvity (NYSE: RVTY) announced the launch of a suite of new solutions and services that expand the frontiers of single cell biology: the HIVE™ CLX Single-Cell RNAseq Solution , BeeNetPLUS analysis workflow, and for single cell researchers based in the United States, a new HIVE CLX Service offering.
  • “The HIVE CLX solution is uniquely designed to enable clinical researchers to overcome challenges often encountered in single cell studies.
  • User-friendly sample capture and storage expands both the scope and geographic reach of single cell research, especially in areas such as innate immunology and infectious disease,” said Jim Flanigon, CEO of Honeycomb.
  • Researchers in the United States may now also take advantage of the HIVE CLX Service offering, made possible by the single cell experts at Honeycomb and Revvity.

The 2023 Ogawa-Yamanaka Stem Cell Prize Awarded to Magdalena Zernicka-Goetz

Retrieved on: 
Tuesday, June 27, 2023

SAN FRANCISCO, June 27, 2023 /PRNewswire/ -- Magdalena Zernicka-Goetz, PhD, was announced today as the recipient of the 2023 Ogawa-Yamanaka Stem Cell Prize by Gladstone Institutes. Zernicka-Goetz is a professor of mammalian development and stem cell biology in the Department of Physiology, Development, and Neuroscience at the University of Cambridge, as well as the Bren Professor of Biology and Biological Engineering at the California Institute of Technology.

Key Points: 
  • SAN FRANCISCO, June 27, 2023 /PRNewswire/ -- Magdalena Zernicka-Goetz, PhD, was announced today as the recipient of the 2023 Ogawa-Yamanaka Stem Cell Prize by Gladstone Institutes.
  • Established in 2015 by a generous gift from the Hiro and Betty Ogawa family, the Ogawa-Yamanaka Stem Cell Prize honors scientists conducting groundbreaking work in translational regenerative medicine using reprogrammed cells.
  • "I am deeply honored to receive the Ogawa-Yamanaka Stem Cell Prize for my work," Zernicka-Goetz says.
  • Zernicka-Goetz was selected for the 2023 Ogawa-Yamanaka Stem Cell Prize by an independent committee of international stem cell experts from a highly competitive pool of nominees.

Lab-grown meat techniques aren't new – cell cultures are common tools in science, but bringing them up to scale to meet society's demand for meat will require further development

Retrieved on: 
Tuesday, June 27, 2023

Scientists have been culturing animal cells in artificial environments since the 1950s, initially focusing on studying developmental biology and cancer.

Key Points: 
  • Scientists have been culturing animal cells in artificial environments since the 1950s, initially focusing on studying developmental biology and cancer.
  • This technique remains one of the major tools in life science research, especially for drug development.
  • Natural media comprise naturally-derived biological fluids, whereas artificial media comprise both organic and inorganic nutrients and compounds.
  • Pros and cons of cultured meat
    There are pros and cons to growing meat through cell culture techniques.

Live Cell Imaging Market worth $4.3 billion | MarketsandMarkets

Retrieved on: 
Tuesday, May 30, 2023

The live cell imaging market in North America has experienced significant growth in recent years, showcasing a robust expansion trajectory, owing to the well-established research infrastructure, strong pharmaceutical and biotech industry, increasing government support for life science research, technological advancements in live cell imaging, and collaborative initiatives contribute to the growth of the live cell imaging market in the North America region.

Key Points: 
  • The live cell imaging market in North America has experienced significant growth in recent years, showcasing a robust expansion trajectory, owing to the well-established research infrastructure, strong pharmaceutical and biotech industry, increasing government support for life science research, technological advancements in live cell imaging, and collaborative initiatives contribute to the growth of the live cell imaging market in the North America region.
  • Live Cell Imaging Market Advantages:
    Real-Time Visualization: Live cell imaging allows researchers to observe and analyze cellular processes in real time, providing dynamic and detailed insights into cellular behavior.
  • Advancements in Imaging Technologies: The live cell imaging market benefits from continuous advancements in imaging technologies, including improved microscope systems, sensitive detectors, and fluorophores.
  • Live Cell Imaging market - Report Highlights:
    The market size is updated for the base year 2022 and forecasted from 2023 to 2028 by studying the impact of the recession on the overall live cell imaging industry.

Live Cell Imaging Market worth $4.3 billion | MarketsandMarkets

Retrieved on: 
Tuesday, May 30, 2023

The live cell imaging market in North America has experienced significant growth in recent years, showcasing a robust expansion trajectory, owing to the well-established research infrastructure, strong pharmaceutical and biotech industry, increasing government support for life science research, technological advancements in live cell imaging, and collaborative initiatives contribute to the growth of the live cell imaging market in the North America region.

Key Points: 
  • The live cell imaging market in North America has experienced significant growth in recent years, showcasing a robust expansion trajectory, owing to the well-established research infrastructure, strong pharmaceutical and biotech industry, increasing government support for life science research, technological advancements in live cell imaging, and collaborative initiatives contribute to the growth of the live cell imaging market in the North America region.
  • Live Cell Imaging Market Advantages:
    Real-Time Visualization: Live cell imaging allows researchers to observe and analyze cellular processes in real time, providing dynamic and detailed insights into cellular behavior.
  • Advancements in Imaging Technologies: The live cell imaging market benefits from continuous advancements in imaging technologies, including improved microscope systems, sensitive detectors, and fluorophores.
  • Live Cell Imaging market - Report Highlights:
    The market size is updated for the base year 2022 and forecasted from 2023 to 2028 by studying the impact of the recession on the overall live cell imaging industry.

Deepcell Launches AI-Powered Single Cell Analysis Platform to Accelerate Cell Biology Discovery and Catalyze Field of Morpholomics

Retrieved on: 
Wednesday, May 17, 2023

Deepcell , a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced the launch of the REM-I Platform , a high-dimensional cell morphology analysis and sorting platform which comprises the REM-I benchtop instrument, Human Foundation Model, and Axon data suite.

Key Points: 
  • Deepcell , a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced the launch of the REM-I Platform , a high-dimensional cell morphology analysis and sorting platform which comprises the REM-I benchtop instrument, Human Foundation Model, and Axon data suite.
  • By bringing together single cell imaging, sorting, and high-dimensional analysis, the REM-I Platform will catalyze new methods of discovery in a wide range of fields including cancer biology, developmental biology, stem cell biology, gene therapy and functional screening, among others.
  • Despite recent advancements in microscopy and flow cytometry, existing tools for cellular quantification and characterization have left the field of cell biology hypothesis bounded and reliant on human interpretation, until now.
  • In addition to these presentations, the company will also reveal the REM-I instrument and demonstrate its capabilities at the conference.

Curio Bioscience Launches Industry’s First Unbiased, High-Resolution, Spatial Transcriptomics Solution

Retrieved on: 
Wednesday, February 8, 2023

Curio Bioscience today announced it has commenced commercial operations with the launch of Curio Seeker, the world’s first high-resolution, whole-transcriptome spatial mapping kit.

Key Points: 
  • Curio Bioscience today announced it has commenced commercial operations with the launch of Curio Seeker, the world’s first high-resolution, whole-transcriptome spatial mapping kit.
  • “Curio Seeker is an innovative, new tool that enables life science researchers to access high-resolution transcriptomics information in their organism of choice.
  • “Curio Seeker has furthered our understanding of the microenvironment and spatial relationships between cells in various tissues of interest.
  • Furthermore, the Curio Seeker kit was both easy to implement and affordable,” said Dr. Angela Pisco, Assistant Director Bioinformatics at Chan Zuckerberg Biohub.